Department of Infectious Diseases, Dr. Rath Research Institute BV, Santa Clara, California, United States of America.
PLoS One. 2019 Apr 18;14(4):e0214763. doi: 10.1371/journal.pone.0214763. eCollection 2019.
In the search for novel agents against oral pathogens in their planktonic and biofilm form, we have focused our attention on 10-undecynoic acid as the representative of the acetylenic fatty acids. Using macro-broth susceptibility testing method we first established MIC value. Next, the MBC value was determined from a broth dilution minimum inhibitory concentration test by sub-culturing it to BHI agar plates that did not contain the test agent. Anti-biofilm efficacy was tested in 96-well plates coated with saliva using BHI broth supplemented with 1% sucrose as a standard approach. Based on obtained results, MIC value for 10-undecynoic acid was established to be 2.5 mg/ml and the MBC value to be 5 mg/ml. The MBIC90 showed to be 2.5 mg/ml, however completed inhibition of biofilm formation was achieved at 5.0 mg/ml. MBBC concentration revealed to be the same as MBC value, causing approximately 30% reduction at the same time in biomass of pre-existing biofilm, whereas application of 7.0 mg/ml of 10-undecynoic acid crossed the 50% eradication mark. Strong anti-adherent effect was observed upon 10-undecynoic acid application at sub-MBC concentrations as well, complemented with suppression of acidogenicity and aciduricity. Thus, we concluded that 10-undecynoic acid might play an important role in the development of alternative or adjunctive antibacterial and anti-biofilm preventive and/or therapeutic approaches.
在寻找针对浮游生物和生物膜形式的口腔病原体的新型药物时,我们将注意力集中在 10-十一烯酸作为炔脂酸的代表上。我们首先使用宏肉汤药敏试验方法确定 MIC 值。接下来,通过在不含测试剂的 BHI 琼脂平板上进行肉汤稀释最小抑菌浓度试验来确定 MBC 值。使用 BHI 肉汤(添加 1%蔗糖作为标准方法)在涂有唾液的 96 孔板中测试抗生物膜功效。根据获得的结果,确定 10-十一烯酸的 MIC 值为 2.5 mg/ml,MBC 值为 5 mg/ml。MBIC90 显示为 2.5 mg/ml,但在 5.0 mg/ml 时完全抑制生物膜形成。MBBC 浓度与 MBC 值相同,同时导致预先存在的生物膜生物量减少约 30%,而应用 10-十一烯酸 7.0 mg/ml 则超过 50%的清除标记。在低于 MBC 浓度下应用 10-十一烯酸时也观察到强烈的抗黏附作用,并伴有抑酸和耐酸作用。因此,我们得出结论,10-十一烯酸可能在开发替代或辅助抗菌和抗生物膜预防和/或治疗方法方面发挥重要作用。